In High-Stakes Meetings, 340B Stakeholders Push to Sway HHS’ Rebate Guidance Ahead of Release

More than a dozen stakeholder groups haver recently met with federal officials about HHS' highly-anticipated 340B rebate guidance.
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Appeals 340B Rebate Ruling, Hospitals Laud Federal Judge’s Rejection of Drugmaker Lawsuit

Johnson & Johnson is appealing a Washington, D.C. federal district judge's ruling on the drugmaker's 340B rebate proposal.
Johnson & Johnson (J&J) has formally appealed a federal judge’s ruling that drugmakers cannot unilaterally implement a 340B rebate model—a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers Urge Appeals Court to Toss Hospital Group’s Cross-Appeal in 340B Rebate Case

Three drugmakers recently asked a federal appeals court in Washington, D.C. to dismiss 340B Health's cross-appeal filed as part of ongoing 340B rebate litigation.
In their second emergency motion this month, a group of drugmakers is urging a federal appeals court to reject a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers, Hospital Group Appeal Dueling Aspects of 340B Rebate Ruling

Multiple drugmakers and an intervening hospital trade group are appealing different aspects of a federal district judge's ruling on 340B rebates.
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Appellate Court Fast-Tracks Drugmakers’ Appeal of 340B Rebate Ruling

A federal appellate court in Washington, D.C. will hear two drugmakers' appeal of a lower courts 340B rebate ruling on an expedited schedule.
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

How Oklahoma Lawmakers Defied Their Governor and Fought Dark Money to Enact a 340B Contract Pharmacy Access Law

Oklahoma state lawmakers overrode their governor's veto to enact a 340B contract pharmacy access law despite strong opposition from dark money groups and conservative influencers.
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Group-Funded Working Paper Calls for Increased 340B Visibility Among Economists 

A recent working paper called for more economists to study the 340B program, which could broaden policymakers' understanding of its impact.
There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Files New Lawsuits to Block 340B Contract Pharmacy Access Laws in Tennessee, Utah

AstraZeneca sued to block Utah's 340B contract pharmacy access law one day after PhRMA challenged Tennessee's similar statute.
AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Applaud Federal Judge’s 340B Rebate Ruling as Drugmakers Mull Next Steps

340B stakeholders are reacting to U.S District Judge Dabney Friedrich's May 15 ruling on a series of controversial drugmaker 340B rebate lawsuits.
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judges Allows 340B Hospital Advocacy Group to Intervene in J&J Rebate Lawsuit

A federal district judge in Washington, D.C. will allow a hospital advocacy group to intervene in another drugmaker 340B rebate lawsuit.
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live